Vimarsana
Biggest News Aggregation in the World

Page 2 - Mars Centre News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mars Centre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mars Centre Today - Breaking & Trending Today

Telo Genomics Presents Positive Results in Assessing MRD in Multiple Myeloma Patients at the International Myeloma Society Annual Meeting - Vimarsana News

Telo Genomics Presents Positive Results in Assessing MRD in Multiple Myeloma Patients at the International Myeloma Society Annual Meeting

Detailed price information for Telo Genomics Corp (TELO-X) from The Globe and Mail including charting and trades.

Telo Genomics Corp.: Telo Genomics Announces Private Placement Increased to $2,766,375 from Previously Announced Private Placement of $2,000,000 - Vimarsana News

Telo Genomics Corp.: Telo Genomics Announces Private Placement Increased to $2,766,375 from Previously Announced Private Placement of $2,000,000

Toronto, Ontario--(Newsfile Corp. - June 6, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "TELO") is pleased to announce that it has increased the size of its previously announced

Telo Genomics Corp.: Telo Genomics Announces Private Placement of Units - Vimarsana News

Telo Genomics Corp.: Telo Genomics Announces Private Placement of Units

Toronto, Ontario--(Newsfile Corp. - May 19, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") is pleased to announce a non-brokered private placement of units ("Units")

Telo Genomics Corp.: Telo Genomics' Multiple Myeloma Drug Resistance Study Results Have Been Selected for Presentation at the 2023 European Hematology Congress - Vimarsana News

Telo Genomics Corp.: Telo Genomics' Multiple Myeloma Drug Resistance Study Results Have Been Selected for Presentation at the 2023 European Hematology Congress

Toronto, Ontario--(Newsfile Corp. - May 4, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") is pleased to announce that the abstract submitted to the European Hematology

Telo Genomics Corp.: Telo Genomics Achieves a Major Milestone - Results of Smoldering Myeloma Study Accepted for Presentation at ASCO Annual Meeting - Vimarsana News

Telo Genomics Corp.: Telo Genomics Achieves a Major Milestone - Results of Smoldering Myeloma Study Accepted for Presentation at ASCO Annual Meeting

Toronto, Ontario--(Newsfile Corp. - April 13, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") is excited to announce that the abstract submitted to the American Society